Serendipity Partners is a trusted discussion partner with extensive medical and scientific knowledge, combined with financial and operational experience, as well as access to the capital necessary to execute. We aim at being the partner of choice in such situations - whether the issues are related to competitive positioning, innovation, geographic expansion, acquisition-based growth or sale of your ownership in the company. We view growing a business with a conservative balance of debt and equity as the most sensible and best risk-adjusted way to create value for our partners and our investors. Our preferred partners are people who have built truly outstanding companies and want to keep building lasting value. They care and can choose their partners.
NORDIC AND EUROPE HEALTH INVEST
Nordic and Europe Health Invest (NEHI), managed by Serendipity Partners, was established to secure a dedicated source of capital to invest within the health care area, leveraging successful long term experience in company management and sector expertise. NEHI will invest in companies that conduct the majority of their business or otherwise have a principal connection to Europe with special emphasis on the Nordics. The remainder Northern European countries will also be a focus area. NEHI has established a well-connected network of senior healthcare professionals, covering several European countries that will help to source deals in a proprietary manner. NEHI is registered by The Financial Supervisory Authority of Norway and has approximately NOK 800 million under management.
NEHI will acquire controlling positions, but also non-majority positions in which the business can be influenced in a value creating manner (e.g., board representation or similar positions, shareholder agreements or similar agreements). The main focus will be mature cash flow positive companies, but the fund may invest up to 20% in earlier stage companies. Half of the investments can be in public companies. NEHI will target companies within a number of healthcare sectors, including pharmaceutical/nutraceuticals, diagnostics, novel products for lowering of health care spending, medical devices and healthcare providers. Deals are evaluated through a well-tested private equity framework. We seek to become partners with public and family business owners, management teams, and excellent CEOs who have as their goal significant long-term growth in their enterprise. We believe that we have assembled the culture, philosophy, tools, knowledge and skills necessary to support this growth-journey.